Terminated PHASE4 INTERVENTIONAL 2-arm NCT01717040

Pioglitazone for the Treatment of Bipolar Depression

Double-Blind, Placebo-Controlled Trial of Pioglitazone for Bipolar Depression

Sponsor: The Depressive and Bipolar Disorder Alternative Treatment Foundation

Conditions Bipolar Disorder Insulin Resistance

Updated 6 times since 2017 Last updated: Nov 30, 2016 Started: Sep 30, 2012 Primary completion: Mar 31, 2016 Completion: Mar 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The study ended early due to budgetary issues

Other Bipolar Disorder trials with similar outcome

Browse all Bipolar Disorder trials

Listed as NCT01717040, this PHASE4 trial focuses on Bipolar Disorder and Insulin Resistance and remains terminated or withdrawn. Sponsored by The Depressive and Bipolar Disorder Alternative Treatment Foundation, it has been updated 6 times since 2012, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated PHASE4

First recorded

Sep 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Depressive and Bipolar Disorder Alternative Treatment Foundation
University Hospitals Cleveland Medical Center

Data source: University Hospitals Cleveland Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cleveland, United States